Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by TheeRookon Mar 26, 2021 1:27pm
189 Views
Post# 32887102

RE:Some Interesting Facts on a Friday

RE:Some Interesting Facts on a Friday Do not know what difference it makes if the FDA has or had not approved any antigen test.
But the FDA did approve 4 more  Rapid Anitgen tests this year. In the FDA Covid Summary,  15 latest  vs 11 in Jan.    Some were the combo type  Flu and Covid.   

 
COVID-19 - Feb 2021
Rapid SARS-CoV-2 and Influenza A+B Antigen Combo Test receives FDA Emergency Use Authorization.
 
PBM and LifeSign introduce the first visually read combo test with EUA. Developed and Made in USA. More info @ LifeSign.



Smokey1958 wrote: 1. NO new rapid antigen test has been authorized by the FDA this year. The FDA site can be a little challenging to navigate so please respond if this is incorrect. 2. NO new rapid antigen test application to HC in weeks.HOLDing long!!!


<< Previous
Bullboard Posts
Next >>